CT-guided percutaneous large-needle aspiration and bleomycin sclerotherapy for bronchogenic cyst: report of four cases.
OBJECTIVE
Fine needle aspiration alone has been used as a treatment for bronchogenic cysts, but is subject to a high rate of recurrence. The purpose of this study was to review our experience with computed tomography (CT)-guided percutaneous large-needle aspiration and bleomycin sclerotherapy of bronchogenic cysts in four patients.


METHODS
Four patients with bronchogenic cysts at subcarinal (n = 1), paraspinal (n = 1), or intrapulmonary (n = 2) sites were treated at two medical centers with percutaneous transthoracic aspiration with a 17.5-gauge needle and sclerotherapy with use of bleomycin as the sclerosant agent. Clinical symptoms were seen in three of the four patients: recurrent cough in two and recurrent chest discomfort and palpitation in one. CT was used to guide the procedures. After sclerotherapy, the sizes of ablated cysts were followed by CT.


RESULTS
At a median follow-up of 10 months (range, 6-14 months), all three patients with symptoms had symptomatic relief and all four patients showed a nearly complete regression of bronchogenic cyst on follow-up CT. No recurrence was encountered. Minor complications included a small asymptomatic pneumothorax at the end of the procedure in one patient and a mild fever (38.0 degrees C-38.5 degrees C) on the first day after sclerotherapy in one patient, which resolved spontaneously without treatment. No major complications occurred.


CONCLUSIONS
CT-guided percutaneous treatment of bronchogenic cysts with large-needle aspiration and bleomycin sclerotherapy was safe and effective in this limited series. Further investigation of this technique is warranted.
Li
Long
L
Department of Interventional Radiology, Nanfang Hospital, Southern Medical University, Guangzhou, China, No. 1838 Guangzhou Ave. N., Guangzhou, Guangdong 510515, China.
Zeng
Xin-Qiao
XQ
Li
Yan-Hao
YH
D001707:Biopsy, Needle / Q000379:methods*; D001761:Bleomycin / Q000008:administration & dosage*; D001994:Bronchogenic Cyst / Q000473:pathology* / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D015641:Radiography, Interventional / Q000379:methods*; D012597:Sclerosing Solutions / Q000008:administration & dosage; D015911:Sclerotherapy / Q000379:methods*; D014057:Tomography, X-Ray Computed / Q000379:methods*; D016896:Treatment Outcome; D055815:Young Adult
D012597:Sclerosing Solutions; D001761:Bleomycin